ConclusionSerum LCN2 concentrations 9 months off-SLIT correlated with clinical reactivity in allergic patients. An increase in the LCN2 levels 9 months after HDM-SLIT was associated with a clinical benefit. Serum LCN2 may thus contribute to assess clinical reactivity in allergic patients.Trial registrationPart of the data were generated fromclinicaltrials.gov Identifier NCT01644617. (Source: World Allergy Organization Journal)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2y26Vkh
Πέμπτη 4 Οκτωβρίου 2018
Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.